Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
07/2004
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
06/2004
06/30/2004EP1433787A1 1,2,3-Thiadiazole derivatives, plant disease controller and method for using them
06/30/2004EP0971908B1 Il-8 receptor antagonists
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122238 for color photography
06/24/2004US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes)
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/22/2004US6753328 Liver cancer; administering taurolidine
06/17/2004WO2004050646A1 1, 2, 5-thiadiazolidin-3-one 1, 1 dioxide derivatives as inhibitors of protein tyrosine phosphatase ptp1b
06/17/2004WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same
06/17/2004US20040116744 Substituted n-phenyl-phenoxy nicotinic acid-(thio)amides and their use as herbicides
06/17/2004US20040116414 Succinoyl aminopyrazoles and related compounds
06/17/2004US20040116404 Sulphones which modulate the action of gamma secretase
06/17/2004US20040115732 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
06/16/2004EP1428534A1 Benzofurazan derivatives for enhancing glutamatergic synaptic responses
06/16/2004EP1427423A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
06/10/2004US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
06/09/2004CN1152869C Anilidothiobiazole metal complex and its preparation and use
06/08/2004US6747041 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
06/08/2004US6746989 Substituted benzoylpyrazoles as herbicides
06/03/2004WO2004046125A1 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same
06/03/2004WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106625 Therapeutic agents useful for treating pain
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/02/2004EP1161424B1 New diazole derivatives as serotonergic agents
06/02/2004EP1087952B1 Benzazole compounds and their use
06/02/2004EP0769966B1 Biotin compounds for targetting tumors and sites of infection
05/2004
05/27/2004WO2004013234A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
05/27/2004US20040102491 Antimicrobial agents
05/27/2004US20040101523 Blocking biosynthesis of neurotransmitters; enzyme inhibitors; cardiovascular disorders
05/27/2004US20040100188 Anthracene derivative and organic electroluminescence device using the derivative
05/26/2004EP1422224A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
05/26/2004EP1420784A1 Compounds effecting glucokinase
05/26/2004EP1165074B1 Viral treatment
05/26/2004EP0740650B1 Codrugs as a method of controlled drug delivery
05/26/2004CN1151140C Glucokinase activators
05/25/2004CA2267471C Bisthiadiazole derivatives and salts thereof, disease controlling agents for agricultural and horticultural use, and method for the use thereof
05/21/2004WO2004041799A1 5- (substituted phenyl) -thiadiazolidine-3-ones and their use as ptp1b
05/21/2004WO2004041798A1 1,2,4-thiadiazole compounds and use thereof
05/21/2004WO2004041264A1 2-oxo-ethanesulfonamide derivates
05/20/2004US20040097495 Method for treating fibrotic diseases or other indications IIIC
05/19/2004EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases
05/19/2004EP1418923A1 Anti-bacterial agents based upon oxoanion binding
05/19/2004EP0975682B1 Group 8-10 transition metal olefin polymerization catalysts
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/18/2004US6737415 Anti-bacterial agents based upon oxoanion binding
05/12/2004EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
05/12/2004CN1149204C 1-heterocycle substd. diarylamines
05/12/2004CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas
05/11/2004US6734186 Phosphodiesterase 2 inhibitor
05/06/2004WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087798 Novel amide compounds
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
05/06/2004US20040087567 Anticancer agents; particularly liver cancer
05/06/2004EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior.
04/2004
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/28/2004EP1413199A1 An agricultural and horticultural disease controller and a method for controlling the diseases
04/28/2004EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
04/28/2004EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/28/2004EP0785928B1 NOVEL N3 S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS
04/27/2004US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent
04/27/2004US6726730 Hair dyes which are readily soluble in water and distinguished by uniform absorption behavior and high washing stability; enable dyeing under gentle and skin-compatible conditions
04/27/2004CA2211110C Preparation of ammonium salts of 3-isopropyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide
04/22/2004WO2004033652A2 Inhibitors of fatty acid amide hydrolase
04/22/2004WO2004033452A1 Thiadiazole compound and use thereof
04/22/2004WO2004033440A1 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
04/22/2004WO2004033419A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004US20040077874 Novel monomers and energy polymerizable compositions; use as waveguides in telecommunications industry
04/22/2004CA2501575A1 Inhibitors of fatty acid amide hydrolase
04/22/2004CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity
04/21/2004EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth
04/21/2004EP1409440A1 A method to inhibit ethylene responses in plants
04/21/2004EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146560C Substituted benzoylpyrazoles as herbicides
04/20/2004US6723716 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
04/15/2004WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
04/15/2004WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
04/15/2004WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
04/14/2004EP0987257B1 1,2,3-thiadiazole derivatives, plant disease controlling agent, and method for use thereof
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines
04/08/2004US20040068012 Anticancer agents; protease enzyme inhibitor
04/07/2004EP1405849A1 Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
04/07/2004EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
04/07/2004EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
04/01/2004US20040063820 Additives including dithiocarbamyl derivatives of 2,5-dimercapto- 1,3,4-thiadiazole (DMTD) useful as curing agents and accelerators. Curable polymer compositions including at least one halogenated polymer and at least one
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 100